The stock of Ares Capital Corporation (NASDAQ:ARCC) registered an increase of 3.94% in short interest. ARCC’s total short interest was 26.73 million shares in September as published by FINRA. Its up 3.94% from 25.72M shares, reported previously. With 1.62 million shares average volume, it will take short sellers 17 days to cover their ARCC’s short positions. About 1.74M shares traded hands. Ares Capital Corporation (NASDAQ:ARCC) has risen 21.33% since February 8, 2016 and is uptrending. It has outperformed by 4.84% the S&P500.
Ares Capital Corporation is a specialty finance firm that is a closed-end, non-diversified management investment company. The company has a market cap of $4.82 billion. The Company’s investment objective is to generate both current income and capital appreciation through debt and equity investments. It has a 11.48 P/E ratio. The Firm invests primarily in the United States middle-market companies.
The institutional sentiment increased to 1.27 in 2016 Q2. Its up 0.43, from 0.84 in 2016Q1. The ratio improved, as 26 funds sold all Ares Capital Corporation shares owned while 87 reduced positions. 33 funds bought stakes while 111 increased positions. They now own 153.44 million shares or 10.49% more from 138.87 million shares in 2016Q1.
Raiff Partners Inc holds 10.62% of its portfolio in Ares Capital Corporation for 260,000 shares. Muzinich & Co. Inc. owns 1.40 million shares or 9.08% of their US portfolio. Moreover, Greenwich Investment Management Inc. has 7.11% invested in the company for 469,682 shares. The Pennsylvania-based Penn Mutual Life Insurance Co has invested 5.23% in the stock. Bruni J V & Co Co, a Colorado-based fund reported 1.58 million shares.
Out of 6 analysts covering Ares Capital (NASDAQ:ARCC), 5 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 83% are positive. Ares Capital has been the topic of 6 analyst reports since September 30, 2015 according to StockzIntelligence Inc. UBS maintained the stock on August 18 with “Buy” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.